Cargando…
Retention in care among HIV-infected pregnant and breastfeeding women on lifelong antiretroviral therapy in Uganda: A retrospective cohort study
BACKGROUND: In 2013, Uganda updated its prevention of maternal-to-child transmission of HIV program to Option B+, which requires that all HIV-infected pregnant and breastfeeding women be started on lifelong antiretroviral therapy (ART) regardless of CD4 count. We describe retention in care and facto...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741223/ https://www.ncbi.nlm.nih.gov/pubmed/29272268 http://dx.doi.org/10.1371/journal.pone.0187605 |
_version_ | 1783288161775910912 |
---|---|
author | Muhumuza, Simon Akello, Evelyn Kyomugisha-Nuwagaba, Charity Baryamutuma, Rose Sebuliba, Isaac Lutalo, Ibrahim M. Kansiime, Edgar Kisaakye, Linda N. Kiragga, Agnes N. King, Rachel Bazeyo, William Lindan, Christina |
author_facet | Muhumuza, Simon Akello, Evelyn Kyomugisha-Nuwagaba, Charity Baryamutuma, Rose Sebuliba, Isaac Lutalo, Ibrahim M. Kansiime, Edgar Kisaakye, Linda N. Kiragga, Agnes N. King, Rachel Bazeyo, William Lindan, Christina |
author_sort | Muhumuza, Simon |
collection | PubMed |
description | BACKGROUND: In 2013, Uganda updated its prevention of maternal-to-child transmission of HIV program to Option B+, which requires that all HIV-infected pregnant and breastfeeding women be started on lifelong antiretroviral therapy (ART) regardless of CD4 count. We describe retention in care and factors associated with loss to follow-up (LTFU) among women initiated on Option B+ as part of an evaluation of the effectiveness of the national program. METHODS: We conducted a retrospective cohort analysis of data abstracted from records of 2,169 women enrolled on Option B+ between January and March 2013 from a representative sample of 145 health facilities in all 24 districts of the Central region of Uganda. We defined retention as “being alive and receiving ART at the last clinic visit”. We used Kaplan-Meier analysis to estimate retention in care and compared differences between women retained in care and those LTFU using the chi-squared test for dichotomized or categorical variables. RESULTS: The median follow-up time was 20.2 months (IQR 4.2–22.5). The proportion of women retained in HIV care at 6, 12 and 18 months post-ART initiation was 74.2%, 66.7% and 62.0%, respectively. Retention at 18 months varied significantly by level of health facility and ranged from 70.0% among those seen at hospitals to 56.6% among those seen at lower level health facilities. LTFU was higher among women aged less than 25 years, 59.3% compared to those aged 25 years and above, 40.7% (p = 0.02); among those attending care at lower level facilities, 44.0% compared to those attending care at hospitals, 34.1% (p = 0.01), and among those who were not tested for CD4 cell count at ART initiation, 69.4% compared to those who were tested, 30.9% (p = 0.002). CONCLUSION: Retention of women who were initiated on Option B+ during the early phases of roll-out was only moderate, and could undermine the effectiveness of the program. Identifying reasons why women drop out and designing targeted interventions for improved retention should be a priority. |
format | Online Article Text |
id | pubmed-5741223 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-57412232018-01-10 Retention in care among HIV-infected pregnant and breastfeeding women on lifelong antiretroviral therapy in Uganda: A retrospective cohort study Muhumuza, Simon Akello, Evelyn Kyomugisha-Nuwagaba, Charity Baryamutuma, Rose Sebuliba, Isaac Lutalo, Ibrahim M. Kansiime, Edgar Kisaakye, Linda N. Kiragga, Agnes N. King, Rachel Bazeyo, William Lindan, Christina PLoS One Research Article BACKGROUND: In 2013, Uganda updated its prevention of maternal-to-child transmission of HIV program to Option B+, which requires that all HIV-infected pregnant and breastfeeding women be started on lifelong antiretroviral therapy (ART) regardless of CD4 count. We describe retention in care and factors associated with loss to follow-up (LTFU) among women initiated on Option B+ as part of an evaluation of the effectiveness of the national program. METHODS: We conducted a retrospective cohort analysis of data abstracted from records of 2,169 women enrolled on Option B+ between January and March 2013 from a representative sample of 145 health facilities in all 24 districts of the Central region of Uganda. We defined retention as “being alive and receiving ART at the last clinic visit”. We used Kaplan-Meier analysis to estimate retention in care and compared differences between women retained in care and those LTFU using the chi-squared test for dichotomized or categorical variables. RESULTS: The median follow-up time was 20.2 months (IQR 4.2–22.5). The proportion of women retained in HIV care at 6, 12 and 18 months post-ART initiation was 74.2%, 66.7% and 62.0%, respectively. Retention at 18 months varied significantly by level of health facility and ranged from 70.0% among those seen at hospitals to 56.6% among those seen at lower level health facilities. LTFU was higher among women aged less than 25 years, 59.3% compared to those aged 25 years and above, 40.7% (p = 0.02); among those attending care at lower level facilities, 44.0% compared to those attending care at hospitals, 34.1% (p = 0.01), and among those who were not tested for CD4 cell count at ART initiation, 69.4% compared to those who were tested, 30.9% (p = 0.002). CONCLUSION: Retention of women who were initiated on Option B+ during the early phases of roll-out was only moderate, and could undermine the effectiveness of the program. Identifying reasons why women drop out and designing targeted interventions for improved retention should be a priority. Public Library of Science 2017-12-22 /pmc/articles/PMC5741223/ /pubmed/29272268 http://dx.doi.org/10.1371/journal.pone.0187605 Text en © 2017 Muhumuza et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Muhumuza, Simon Akello, Evelyn Kyomugisha-Nuwagaba, Charity Baryamutuma, Rose Sebuliba, Isaac Lutalo, Ibrahim M. Kansiime, Edgar Kisaakye, Linda N. Kiragga, Agnes N. King, Rachel Bazeyo, William Lindan, Christina Retention in care among HIV-infected pregnant and breastfeeding women on lifelong antiretroviral therapy in Uganda: A retrospective cohort study |
title | Retention in care among HIV-infected pregnant and breastfeeding women on lifelong antiretroviral therapy in Uganda: A retrospective cohort study |
title_full | Retention in care among HIV-infected pregnant and breastfeeding women on lifelong antiretroviral therapy in Uganda: A retrospective cohort study |
title_fullStr | Retention in care among HIV-infected pregnant and breastfeeding women on lifelong antiretroviral therapy in Uganda: A retrospective cohort study |
title_full_unstemmed | Retention in care among HIV-infected pregnant and breastfeeding women on lifelong antiretroviral therapy in Uganda: A retrospective cohort study |
title_short | Retention in care among HIV-infected pregnant and breastfeeding women on lifelong antiretroviral therapy in Uganda: A retrospective cohort study |
title_sort | retention in care among hiv-infected pregnant and breastfeeding women on lifelong antiretroviral therapy in uganda: a retrospective cohort study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741223/ https://www.ncbi.nlm.nih.gov/pubmed/29272268 http://dx.doi.org/10.1371/journal.pone.0187605 |
work_keys_str_mv | AT muhumuzasimon retentionincareamonghivinfectedpregnantandbreastfeedingwomenonlifelongantiretroviraltherapyinugandaaretrospectivecohortstudy AT akelloevelyn retentionincareamonghivinfectedpregnantandbreastfeedingwomenonlifelongantiretroviraltherapyinugandaaretrospectivecohortstudy AT kyomugishanuwagabacharity retentionincareamonghivinfectedpregnantandbreastfeedingwomenonlifelongantiretroviraltherapyinugandaaretrospectivecohortstudy AT baryamutumarose retentionincareamonghivinfectedpregnantandbreastfeedingwomenonlifelongantiretroviraltherapyinugandaaretrospectivecohortstudy AT sebulibaisaac retentionincareamonghivinfectedpregnantandbreastfeedingwomenonlifelongantiretroviraltherapyinugandaaretrospectivecohortstudy AT lutaloibrahimm retentionincareamonghivinfectedpregnantandbreastfeedingwomenonlifelongantiretroviraltherapyinugandaaretrospectivecohortstudy AT kansiimeedgar retentionincareamonghivinfectedpregnantandbreastfeedingwomenonlifelongantiretroviraltherapyinugandaaretrospectivecohortstudy AT kisaakyelindan retentionincareamonghivinfectedpregnantandbreastfeedingwomenonlifelongantiretroviraltherapyinugandaaretrospectivecohortstudy AT kiraggaagnesn retentionincareamonghivinfectedpregnantandbreastfeedingwomenonlifelongantiretroviraltherapyinugandaaretrospectivecohortstudy AT kingrachel retentionincareamonghivinfectedpregnantandbreastfeedingwomenonlifelongantiretroviraltherapyinugandaaretrospectivecohortstudy AT bazeyowilliam retentionincareamonghivinfectedpregnantandbreastfeedingwomenonlifelongantiretroviraltherapyinugandaaretrospectivecohortstudy AT lindanchristina retentionincareamonghivinfectedpregnantandbreastfeedingwomenonlifelongantiretroviraltherapyinugandaaretrospectivecohortstudy |